Corbus Pharmaceuticals Holdings (CRBP) Change in Acquisitions & Divestments (2021 - 2025)

Corbus Pharmaceuticals Holdings' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $37.5 million for Q3 2025.

• On a quarterly basis, Change in Acquisitions & Divestments rose 59.67% year-over-year to $37.5 million in Q3 2025; TTM through Sep 2025 was $148.5 million, a 179.01% increase from a year earlier, with the FY2024 full-year figure at $59.5 million, down 14.43% from the prior year.
• Change in Acquisitions & Divestments grew to $37.5 million in Q3 2025 per CRBP's latest filing, from $35.4 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $55.7 million in Q1 2025 and bottomed at $6.9 million in Q4 2021.
• The 5-year median for Change in Acquisitions & Divestments is $19.1 million (2023), against an average of $23.8 million.
• Across the five-year window, Change in Acquisitions & Divestments sank 61.86% in 2023 and jumped 627.33% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $6.9 million in 2021, then soared by 36.77% to $9.4 million in 2022, then soared by 46.18% to $13.7 million in 2023, then jumped by 45.59% to $20.0 million in 2024, then soared by 87.67% to $37.5 million in 2025.
• Per Business Quant, the three latest CRBP Change in Acquisitions & Divestments figures stand at $37.5 million (Q3 2025), $35.4 million (Q2 2025), and $55.7 million (Q1 2025).